Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Novartis ( (NVS) ).
On January 31, 2025, Novartis AG released its Annual Report for 2024, alongside its ‘Novartis in Society – Integrated Report 2024.’ This announcement underscores the company’s commitment to transparency and accountability in its financial and societal contributions, enhancing its reputation in the industry and providing stakeholders with a comprehensive overview of its annual performance and impact.
More about Novartis
Novartis AG is a leading pharmaceutical company based in Basel, Switzerland. It specializes in the development and manufacturing of healthcare products, focusing on innovative medicines and treatments for various diseases.
YTD Price Performance: 7.83%
Average Trading Volume: 1,332,681
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $204.2B
See more insights into NVS stock on TipRanks’ Stock Analysis page.
